<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors></authors><secondary-authors><author><style face="normal" font="default" size="100%">Stone, Gregg W.</style></author><author><style face="normal" font="default" size="100%">Wolff, Matthew</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">ACUITY/ACUITY Timing</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2006</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2006-04-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">14-15</style></pages><abstract><style  face="normal" font="default" size="100%">The central issue examined by the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) Trial, according to principal investigator Gregg W. Stone, MD, Columbia University Medical Center and the Cardiovascular Research Foundation, was “how best to anticoagulate patients with acute coronary syndromes (ACS).” ACUITY was a two part study; a main study evaluating optimum anticoagulation strategies, with a sub-study (ACUITY-TIMING) that looked at timing of anticoagulation therapy.</style></abstract><number><style face="normal" font="default" size="100%">1</style></number><volume><style face="normal" font="default" size="100%">6</style></volume></record></records></xml>